A polyphenol-rich formulation may enhance the benefits of mind-body
practices: published study on holistic well-being.

Riding the wave of its new range of sports nutrition ingredients launched at
SupplySide West, Fytexia announces the publication of a clinical study in the
International Journal of Food Sciences and Nutrition demonstrating the benefits of
HolisFiit®.

“Regular consumption of HolisFiit, a polyphenol-rich extract-based food
supplement, improves mind and body well-being of overweight and slightly
obese volunteers: a randomized, double-blind, parallel trial”
Cindy Romain, Pedro Emilio Alcaraz, Linda Haiwon Chung,
and Julien Cases. Published online,
Feb. 23, 2017.

Fytexia’s years of experience in the field of polyphenol science led to a think-out-thebox
concept for an ingredient ideally suited for the sports nutrition market, yet
offering a product tailored to the growing practice of mind-body exercise.

Modern lifestyles face increasing demands for natural solutions to help improve
general well-being. Accordingly, mind-body activities, such as yoga, Pilates, and Taïchi,
have shown considerable growth; 36.7 million American adults have chosen to
join the yoga community – a number that increased by 79% in the last 4 years alone.

Fytexia’s HolisFiit is a polyphenol-rich ingredient designed to support focus and
optimize mind-body workouts. The formula combines the health benefits of green
tea and yerba mate with botanical extracts (grapefruit, black carrot and grape)
inspired from the Mediterranean diet, enhanced by the addition of vitamin B3.

A 4-month double-blind, randomized, placebo-controlled clinical study in 33 subjects
(aged 30 to 50 years) demonstrates the benefits of supplementation with 1 gram of
HolisFiit a day. The study was conducted in collaboration with the Research Center
of High Performance Sport, University of Murcia, Spain.

By helping people to reach physical and mental balance, HolisFiit contributes to
enhanced body-mind capacities. Daily supplementation led to a 43% improvement
in the Athens Insomnia Scale score: a significant increase in overall sleep quality
through a facilitation of falling asleep and a significant increase in total sleep
duration.

These improvements in sleep markers impacted the feeling of well-being in the daytime:
in association with a 67% improvement in well-being, subjects in the HolisFiit
group experienced an 80% increase in functioning capacity during the day.

Subjects supplemented with HolisFiit reported a significantly higher overall feeling of
vitality compared to the placebo group. General physical health perception
increased by 10% with HolisFiit, based on questions from the validated SF-36 health
questionnaire.

Moreover, in the lean-to-fat mass ratio, body composition significantly rebalanced
by 7.4%, signifying an improved body tone for the HolisFiit-supplemented group.

Fytexia’s decision to initiate this breakthrough innovation was inspired by the
demand from consumers for a safe formula supported by strong human clinical
evidence, and made from non-GMO ingredients they can recognize and trust.

With HolisFiit, the French company Fytexia showcases its straight-to-the-point
approach in helping sports nutrition product formulators, 96% of whom believe that
mind-body exercise products must provide benefits in both physical health and
mental well-being for body-mind balance (internal survey by Fytexia of more than 50
participants).
For more details, please contact Fytexia at lnogier@fytexia.com

New York City, NY (PRWEB) March 17, 2017 – Kyowa is pleased to announce the launch of its premium branded ingredient Setria® Glutathione in the European markets.

Setria® is a branded form of glutathione an antioxidant present in almost all cells of the body. Glutathione plays an important role in numerous bodily processes, including antioxidant protection, detoxification and immune system fortification. Glutathione may be depleted as a result of poor lifestyle choices, stress and natural ageing. Supplementation is needed if ones diet does not include abundant unprocessed fruit and vegetables.

Kyowa Hakko has been manufacturing glutathione since the 1960s using a patented fermentation process. This proprietary technology, several years in the making, further distinguishes Setria® glutathione from generic glutathione in the market. Setria is a high purity form of glutathione, vegetarian and allergen-free with no animal or human raw materials used. It is clinically tested and has been shown to increase the levels of glutathione in the blood when taken orally.

Setria® Glutathione is a unique tripeptide consisting of three important amino acids glutamic acid, cysteine and glycine. The name SETRIA comes from SET the balance + TRI, of tripeptides. In other words, SETRIA is a tripeptide that helps to set body’s glutathione back to balance.

Setria® Glutathione is already successfully sold in the USA and Asia as a key antioxidant ingredient and is now available to European dietary supplement market.

For more information about Setria®Glutathione, visit www.setriaglutathione.com

References

¹ Richie JP Jr, Nichenametla S, Neidig W, Calcagnotto A, Haley JS, Schell TD, Muscat JE. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition. May 2014: 1436-6207. doi: 10.1007/s00394-014-0706-z

The third edition of NutraIngredients Awards – rewarding true innovation and cutting edge research in health foods, supplements and nutrition – will take place on May 10thin Geneva, after second day of Vitafoods Europe. 

Lipofoods with the aim to reinforce its brand awareness and positioning as microencapsulation technological ingredients supplier has decided to support this prestigious event.

Furthermore we have decided to enter the awards competition in 3 different categories, showcasing and communicating the competitive technical advantages and unique marketing positioning of our branded ingredients:

Ingredient of the Year – Sport & Energy with NEWCAFF™ microcapsules, novel delivery system which has been designed by Lipofoods to mask caffeine objectionable bitter taste while providing its sustained release for over 4 hours targeting predominantly energy & endurance sports nutrition products looking for the slow energy release claim and with a better sensory profile.
Ingredient of the Year – Heart Health with LIPOPHYTOL^®, water dispersible microencapsulated free phytosterols suitable for a wide range of different food matrices. Responding to the strong awareness of the ecological impact of standard palm oil cultivation, implications in the development of hearth diseases and the complexity associated to the addition of phytosterols into different food matrices, LIPOFOODS will present the PALM FREE version of LIPOPHYTOL^®.

Ingredient of the Year – Infant Nutrition with LIPOFER® a water dispersible micronized source of iron that has been microencapsulated to enhance iron absorption and to reduce undesirable organoleptic attributes, thus enabling the fortification and supplementation of infant formulas with this essential nutrient.

Blis Technologies and Stratum Nutrition announce the results of a new clinical study in children reporting the beneficial effects of the oral-cavity probiotic, BLIS K12™ (Streptococcus salivarius K12), on reducing the occurrences of streptococcal pharyngo-tonsillitis (PT) and acute otitis media (AOM) in young children with no previous history of either condition. This study was recently published in theEuropean Review for Medical and Pharmacological Sciences and supports the existing body of clinical research showing the benefits of BLIS K12 for reducing streptococcal PT and AOM in children, as well as streptococcal PT in adults already predisposed to recurring episodes of these conditions.

This clinical trial was conducted by Di Pierro et al (Milan, Italy) on 222 otherwise healthy male and female ethnically diverse children around the age of 3 years. Children were randomized into 2 demographically equivalent groups (n=111 per group), with one group given BLIS K12 probiotic (1 slow-dissolving tablet daily), while the other group served as the untreated control. The BLIS K12 probiotic was administered for 6 months with an additional 3-month follow-up in a sub-population (n=29/group).

At the end of the 6-month intervention period, the investigators reported the number of children diagnosed with streptococcal PT and AOM, in the control group was 54 (49%) and 89 (80%) respectively, compared to 18 (16%; P<0.01) and 49 (44%; P<0.01) in the BLIS K12 probiotic group. The total number of episodes (including recurrent cases during the study period) of PT and AOM was significantly lower (P<0.01) in the BLIS K12 group (21, 53) compared to control (67, 101) respectively.

Dr. Joseph L. Evans (Founder & President, P & N Development Ventures, Saint Louis, MO), comments on the study:

“Once again, the clinical efficacy of BLIS K12 is reported in an entirely new population of children who might potentially benefit. It is one achievement to demonstrate the protective benefits in a population that has proven to be susceptible. It is an altogether new challenge to show an analogous benefit in those who had exhibited no previous susceptibility. PT and AOM are the primary drivers of practitioner visits in this population, with no proven or approved prophylactic agents available.”

BLIS K12™ is a unique strain of Streptococcus salivarius, a bacterial species commonly found in the oral cavity of healthy individuals. Supporting a beneficial microbiome in the oral cavity through BLIS K12 supplementation can be one of the best ways to maintain continued optimal oral hygiene and upper respiratory health. For more information on this study and other studies evaluating BLIS K12 and BLIS M18, contact Dr. Kevin Ruff at kruff@esmingredients.com.

Rimouski (Quebec), February 20, 2017 – innoVactiv, a Canadian company dedicated to the development of science-based specialty ingredients, is pleased to report that InSea2® produced statistically significant positive results on cognition in a recently completed human clinical trial conducted by the Brain, Performance and Nutrition Research Center of Northumbria University (UK).
In previous human studies, InSea2® has shown to optimize carbohydrate absorption and assimilation by slowing down the activity of digestive enzymes alpha-amylase and alpha-glucosidase. InSea2® thus reduces the fluctuations in blood sugar induced by dietary carbohydrates, while reducing insulin levels and improving surrogate markers of insulin sensitivity. Although the brain relies on glucose for energy production, its optimal functioning is affected when blood glucose levels fluctuate up and down after a high-carb meal. Several studies have shown that attention, cognition, and even driving can be impaired after a meal due to occurrence of postprandial hypoglycemia or to amino acid imbalances in the brain’s chemistry that induce sleepiness. Therefore, this trial aimed to evaluate if the well-demonstrated glucose-stabilizing effects of InSea2® could help optimize brain function after a high-carb meal.

The present randomized, double-blind, placebo-controlled study involved 60 healthy male and female subjects. On study day, each volunteer underwent baseline cognitive tests to measure Attention, Performance and Error rate using the Computerised Mental Performance Assessment System (COMPASS). Subjects then took 500 mg of InSea2® before eating a high-carb meal. Cognitive tests were repeated every 40 minutes over a 3 hour and 10 minute period. Results showed statistically-significant improvements in cognitive function, such as increased accuracy on Digit Vigilance and Choice Reaction tests. The InSea2®-treated subjects were also significantly less likely to make errors in repetitive, computer tasks. In line with its blood-glucose optimizing effects, these significant cognitive benefits have been noticed following a single intake of InSea2®, and no side effects were reported.

“We are really excited about these new results highlighting immediate and tangible benefits from optimizing glucose absorption. Everyone can experience periods of tiredness or sluggishness after a meal, and finding a non-stimulant, caffeine-free solution to this problem is now within reach with InSea2®”, explains Jocelyn Bérubé, Executive and Scientific Director at innoVactiv. “Blood sugar control is pivotal to many physiological processes impacting several of our body’s key functions. By optimizing post-meal blood glucose, we can thus expect to see benefits to various body structures and functions, such as the cognitive benefits measured in this new study”, added Mr. Bérubé.

“These new clinical results are just one example of a “functional benefit” of blood sugar control, one which can be more easily conveyed to consumers” added Patrice Dionne, CEO of innoVactiv.

Full study results will be disclosed at the upcoming Engredea tradeshow (Booth # 765; March 10-12, 2017, Anaheim, CA).

Oral Availability of Glutathione A Deeper Dive into the Master Antioxidant

Kyowa has partnered with Natural Medicine Journal to create a Research Guide on glutathione.

Read the Research guide here:

http://www.naturalmedicinejournal.com/sites/default/files/glutathione_final_digital.pdf

Geneva, Switzerland, Vitafoods Europe – Taiyo will present new additions to its Sunfiber® portfolio, an all-natural, soluble dietary fiber that can now also be used as a sweetener. The Sweet-Sunfiber® compound contains an Isomalto-oligosaccharide whereas the Sunfiber®-Matcha Honey variant promotes natural sweetness with a green tea tang. Both combine the health-boosting properties and technological benefits of Taiyo’s dietary fiber ingredient with a mildly sweet taste profile.
Sweet-Sunfiber® provides end products with a sugar-like sweetness – combined with a dietary fiber boost. The Isomalto-oligosaccharide convinces with an excellent nutritional profile: fewer calories, a low glycemic index, and tooth-friendliness. Sunfiber® as a soluble fiber has various prebiotic properties, promoting the growth of short-chain fatty acids in the colon, which helps to prevent nutrition-related diseases. As the fermentation rate of Taiyo’s ingredient is very slow, it doesn’t produce painful gas, cramping or discomfort. This is particularly important for patients with irritable bowel syndrome, who often struggle to tolerate dietary fibers. However, Sunfiber® products are proven to be well tolerated.

The Sunfiber® range also benefits from optimized technological benefits. The ingredients are highly water soluble, stable at different pH levels and temperatures, and can therefore be used for a variety of applications as dairy and bakery products, meats and sausages, beverages, ice-creams and confectioneries.

“More and more consumers are looking for products with health benefits. Ultimately, however, the factor that defines the success of a product is taste. Particularly for reduced sugar products, getting the sweetness profile right can be challenging. It is all about achieving the ‘gold standard’ sugar taste with an improved nutritional profile,” says Dr Stefan Siebrecht, Managing Director of Taiyo GmbH. “Our new compound, comprising an Isomalto-oligosaccharide, matches both demands: Sweet-Sunfiber® guarantees a balanced sweetness with fewer calories while providing a high concentration of well-tolerated dietary fibers.”

The biocertified Sunfiber®-Matcha Honey offers an interesting mixture of sweetness and refreshingly bitter green tea flavor. It provides a simple way to combine dietary fiber enrichment with an extraordinary taste and health-boosting properties. In general, Matcha is known for its antioxidant effect, and honey for its antibacterial properties.

All Sunfiber® variants are clinically proven to lower the glycemic index, contributing to stabilized blood glucose levels. Furthermore, the prebiotic fiber promotes the health and function of the intestinal tract for general wellbeing. Sunfiber® also qualifies as an organic material, is non-GMO and a 100% gluten-free product. It is Kosher and Halal certified and perfectly suitable for vegetarians and vegans.

Kaneka Ubiquinol^™ is the reduced, active antioxidant form of Coenzyme Q10 (CoQ10).

Produced naturally within the body, ubiquinol is CoQ10 that has been converted into a substance necessary for use in cellular energy production. In addition to its critical role in energy production, it is one of the most powerful known lipid-soluble antioxidant available, protecting the body’s cells from damage caused by oxidative stress and free radicals. The body’s ability to produce CoQ10 declines with age, as does the ability to convert it into ubiquinol. Ubiquinol levels have been shown to be suppressed in older individuals and those with cardiovascular, neurological, liver- and diabetes-related conditions.

Mythocondro®  has a brand-new user friendly DEDICATED WEBSITE designed to provide all of the featured aspects of this pioneering vegetarian alternative of Chondroitin Sulfate.

Mythocondro® is the first Non-Animal Chondroitin Sulfate obtained through a patented fermentation-based manufacturing process. It warrants high purity, clear identity profile, batch-to-batch reproducibility, established safety, very low content of proteins and other macro(molecules) as well as an improved biological activity. Clinically tested,  it is suitable for vegetarians and  free from religious restrictions.

The website has an easy navigation and impresses with features bright colors and fresh structure allowing the readers to view the advancements and details that make Mythocondro® the only special Animal-free Chondroitin Sulfate.

“Although chondroitin sulfate is a recognized beneficial ingredients for joint health not all market players are enough aware about the issues related to the origin, the quality, the efficacy and the safety of animal sources available so far.” – said Silvia Pisoni, Marketing Manager of Gnosis – . “Misplaced supply chain traceability and missed guidelines have adversely affected the global nutraceutical industry and undermined chondroitin sulfate popularity. Mythocondro^®, the ground-breaking vegetarian alternative of CS, resolves any of the concerns of animal-derived CS because it is produced under strict quality standards with defined, clean and controlled origin.”

Mythocondro^® brand-new website offers a 360-degree tours into in the world of chondroitin, with a user-friendly description of the black side aspects of animal-derived CS and the white side evolution of this Animal-free Chondroitin Sulfate, going deep inside specific aspects that characterize its bioavailability, efficacy and safety.

Direct options to share information across all major social networking site are available …you just have to join the evolution at  www.mythocondro.com!

For more information contact marketing@gnosis-bio.com

Valensa International announced  that it has begun offering its Chia Gold Stabilized Chia Seed Oil in Europe. The company gained Novel Food approval for the ingredient via a substantial equivalence opinion in September of last year. The ingredient, which was launched by Valensa in the United States in 2012 is one of the top-selling Chia-based Omega-3 ingredients in the US market – known for its exceptional shelf-stability, pleasant taste and overall quality based on Valensa’s proprietary processing technologies. Chia Gold contains 550 milligrams (mg) of ALA Omega-3 per gram of oil. It is a part of Valensa’s industry-leading portfolio of chia-based ingredients, developed with the company’s solvent-free, supercritical CO2 extraction technology and proprietary O2B® Peroxidation Blocker stabilization technology. Chia Gold is available for use in the same food categories and at the same use levels as Europe’s existing chia oils, which includes its use in fats and oils (≤ 10%) and in food supplements (≤ 2 g/day).

According to Sylvia de Jong, Vice President of Sales & Marketing at Valensa, Novel Food approval for Chia Gold will allow European consumer products companies to enhance the Omega-3 nutritional profile of their products in applications where taste and product stability are primary concerns. “Omega-3s are among the most desirable nutritional ingredients in Europe and Chia is emerging with consumers as a popular source – because it is plant-based and sustainable. It has the potential to become a differentiator in a broad range of consumer products,” she said. “With Chia Gold, consumer product developers can use the best-tasting, most shelf-stable chia oil product on the market – unleashing their creativity in formulation while assuring the highest quality for their customers and building their brands,” she added.

Advanced, Patented Processing Technology
According to Stephen Hill, Vice President of Product Development, “Valensa utilizes its state-of-the-art Deep Extract® Supercritical CO2 extraction process (solvent-free) to produce the highest Omega-3 concentration, highest purity chia oil in conditions that delay the onset of rancidification – particularly when compared to conventional expeller-press processes. This process delivers the best tasting chia oil on the market – an important factor for taste-sensitive formulations like gummies and nutrition bars”.

In addition, Valensa utilizes its patented O2B® Peroxidation Blocker technology to stabilize Chia Gold and employs a Rancimat® device to validate shelf life. Years of data with Chia Gold show an industry-leading stability for the ingredient and a shelf-life of at least 2 years, even at room temperature. As a company, Valensa holds 13 U.S. and International patents for Chia oil and has a state-of-the art extraction facility that maximizes the quality, stability and shelf life of the oil produced. Chia Gold raw materials are ethically and sustainably sourced and monitored for quality.

Sylvia de Jong: “After the reception that Chia Gold has had in the United States, we’re excited to be able to offer this ingredient in the European market. We feel that consumer product companies will embrace the market opportunities this special value proposition will enable.”